FTC Narrowly Okays AbbVie/Allergan Merger As Dissenter Slams Divestitures To AstraZeneca, Nestlé

 
• By Brenda Sandburg
Close-up Of King Chess Pieces On Wooden Blocks With Mergers And Acquisitions
FTC Commissioners disagree on adequacy of AbbVie/Allergan divestitures

More from Compliance

More from Pink Sheet